Clinical trial · Interventional
Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplantation
Application of the Biological Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplant
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Globally there have been about 45,000 kidney transplants last year. Currently, the overall survival of renal transplant receptors is 95% in the first year and 85% at 5 years. A major challenge to overcome by the renal transplant surgeons, are surgical complications which may impact on patient morbidity and mortality, as well as graft function. The aim of the study is to assess whether application of fibrin seal prevents postoperative complications in patients undergoing kidney transplantation. Controlled clinical trial with single-blind evaluation in patients surgically intervened kidney transplantation. It will include all patients undergoing renal transplantation in this Medical Center, any gender and over than 16 years and under 60 years.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphocele | — | UNRESOLVED | — |
| Postoperative Infection | — | UNRESOLVED | — |
| Urological System Complication of Procedure | — | UNRESOLVED | — |
| Vascular Postoperative Complications | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fibrin Glue | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Control
- description
- Patients fron this group do not receive the fibrin sealant
- type
- ACTIVE_COMPARATOR
- label
- Fibrin group
- description
- Patients from this group will receive the fibrin sealant
- interventionNames
- Biological: Fibrin Glue
Primary outcomes (1)
- measure
- Postoperative Complications
- timeFrame
- 1 year
- description
- Patients will be followed from the immediate postoperative period until discharge, and at follow up every week the first month, then every 15 days the second month, and monthly until one year follow up. Identifying any kind of complication derived from the surgical procedure.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Patients candidates to renal transplantation Exclusion Criteria: * Patients with known allergy to products of fibrin seal
References
Publications (0)
Data not yet available